Ionis Pharmaceuticals (IONS) awards 3,399 RSUs to board director Reikes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Reikes Peter N reported acquisition or exercise transactions in this Form 4 filing.
Ionis Pharmaceuticals Inc granted director Peter N Reikes 3,399 Restricted Stock Units on July 15, 2026 under its Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. The RSUs vest in three equal annual installments starting July 15, 2027 and will be fully vested on July 15, 2029. Following this award, Reikes holds 3,399 RSUs directly, all unvested as of the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Reikes Peter N
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 3,399 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,399 shares (Direct)
Footnotes (1)
- Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Grant on July 15, 2026 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on July 15, 2027. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 15, 2029. The RSU is vested as to 0 shares on July 15, 2026.
Key Figures
RSUs granted: 3,399 Restricted Stock Units
Underlying common shares: 3,399 shares of Common Stock
Vesting installments: 3 equal annual installments
+2 more
5 metrics
RSUs granted
3,399 Restricted Stock Units
Grant to director Peter N Reikes on July 15, 2026
Underlying common shares
3,399 shares of Common Stock
Each RSU represents a contingent right to one share or its cash value
Vesting installments
3 equal annual installments
First installment vests on July 15, 2027
Full vesting date
July 15, 2029
RSU award shall be fully vested on this date
Post-grant RSU holdings
3,399 Restricted Stock Units
Total direct RSU holdings following the reported transaction
Key Terms
Restricted Stock Unit, contingent right, Amended and Restated 2002 Non-Employee Directors' Stock Option Plan
3 terms
Restricted Stock Unit financial
"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value"
Amended and Restated 2002 Non-Employee Directors' Stock Option Plan financial
"Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity award did Ionis Pharmaceuticals (IONS) grant to Peter N Reikes?
Ionis Pharmaceuticals granted director Peter N Reikes 3,399 Restricted Stock Units on July 15, 2026. Each unit provides a contingent right to receive one share of Ionis common stock or its equivalent cash value, subject to a multi-year vesting schedule through July 15, 2029.
How do the Ionis Pharmaceuticals (IONS) RSUs for Peter N Reikes vest over time?
The 3,399 RSUs granted to Peter N Reikes vest in three equal annual installments. The first installment vests on July 15, 2027, with additional installments on the following two anniversaries, so the award is fully vested on July 15, 2029.
When will the Ionis Pharmaceuticals (IONS) RSUs granted to Peter N Reikes be fully vested?
The RSU award to Peter N Reikes is scheduled to be fully vested on July 15, 2029. Vesting occurs in three equal annual installments beginning July 15, 2027, and no shares were vested as of the grant date, July 15, 2026.
What does each Restricted Stock Unit represent in the Ionis (IONS) grant to Peter N Reikes?
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Upon vesting, the RSUs will be settled in whole shares of common stock or cash, as may be determined by the company.
How many Ionis Pharmaceuticals (IONS) RSUs does Peter N Reikes hold after this grant?
Following the July 15, 2026 grant, Peter N Reikes holds 3,399 Restricted Stock Units directly. According to the grant terms, the RSUs are vested as to 0 shares on the grant date, with vesting commencing in 2027 and finishing in 2029.